Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: d2006s...Deb, with all due respect how can you or anyone else

Laurie:

No big deal, but I believe the last line that you quote should read:

"the Board anticipates paying a dividend of between $60 and $72 per share."

Not:

"the Board anticipates paying a dividend of between $60 and 472 per share."

Happy New Year!

SDC 

Share
New Message
Please login to post a reply